168 related articles for article (PubMed ID: 27523481)
1. Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.
Bogorad MI; Searson PC
Integr Biol (Camb); 2016 Sep; 8(9):976-84. PubMed ID: 27523481
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination.
Chen EC; Broccatelli F; Plise E; Chen B; Liu L; Cheong J; Zhang S; Jorski J; Gaffney K; Umemoto KK; Salphati L
Mol Pharm; 2018 Nov; 15(11):5103-5113. PubMed ID: 30222362
[TBL] [Abstract][Full Text] [Related]
4. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
Mukkavilli R; Jadhav G; Vangala S
Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
[TBL] [Abstract][Full Text] [Related]
6. Leveraging avidin-biotin interaction to quantify permeability property of microvessels-on-a-chip networks.
Gao F; Sun H; Li X; He P
Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H71-H86. PubMed ID: 34767485
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro.
Huang JF; Wen CJ; Zhao GZ; Dai Y; Li Y; Wu LX; Zhou HH
Cancer Chemother Pharmacol; 2018 Aug; 82(2):199-210. PubMed ID: 29777275
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo.
Hill CR; Jamieson D; Thomas HD; Brown CD; Boddy AV; Veal GJ
Biochem Pharmacol; 2013 Jan; 85(1):29-37. PubMed ID: 23063411
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs).
Gallagher E; Minn I; Chambers JE; Searson PC
Fluids Barriers CNS; 2016 Jul; 13(1):10. PubMed ID: 27396356
[TBL] [Abstract][Full Text] [Related]
10. Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier.
Colclough N; Alluri RV; Tucker JW; Gozalpour E; Li D; Du H; Li W; Harlfinger S; O'Neill DJ; Sproat GG; Chen K; Yan Y; McGinnity DF
Drug Metab Dispos; 2024 Jan; 52(2):95-105. PubMed ID: 38071533
[TBL] [Abstract][Full Text] [Related]
11. Establishment of optimized MDCK cell lines for reliable efflux transport studies.
Gartzke D; Fricker G
J Pharm Sci; 2014 Apr; 103(4):1298-304. PubMed ID: 24532159
[TBL] [Abstract][Full Text] [Related]
12. Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2- Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration.
Liu H; Yu N; Lu S; Ito S; Zhang X; Prasad B; He E; Lu X; Li Y; Wang F; Xu H; An G; Unadkat JD; Kusuhara H; Sugiyama Y; Sahi J
Drug Metab Dispos; 2015 Jul; 43(7):1008-18. PubMed ID: 25908246
[TBL] [Abstract][Full Text] [Related]
13. A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.
Karlgren M; Simoff I; Backlund M; Wegler C; Keiser M; Handin N; Müller J; Lundquist P; Jareborg AC; Oswald S; Artursson P
J Pharm Sci; 2017 Sep; 106(9):2909-2913. PubMed ID: 28450237
[TBL] [Abstract][Full Text] [Related]
14. Development of a new permeability assay using low-efflux MDCKII cells.
Di L; Whitney-Pickett C; Umland JP; Zhang H; Zhang X; Gebhard DF; Lai Y; Federico JJ; Davidson RE; Smith R; Reyner EL; Lee C; Feng B; Rotter C; Varma MV; Kempshall S; Fenner K; El-Kattan AF; Liston TE; Troutman MD
J Pharm Sci; 2011 Nov; 100(11):4974-85. PubMed ID: 21766308
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.
Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC
Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1.
Wegler C; Gazit M; Issa K; Subramaniam S; Artursson P; Karlgren M
J Pharm Sci; 2021 Jan; 110(1):388-396. PubMed ID: 33007277
[TBL] [Abstract][Full Text] [Related]
17. Application of a high-resolution in vitro human MDR1-MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration.
Jiang L; Kumar S; Nuechterlein M; Reyes M; Tran D; Cabebe C; Chiang P; Reynolds J; Carrier S; Sun Y; Eddershaw P; Hay T; Chen W; Feng B
Pharmacol Res Perspect; 2022 Feb; 10(1):e00932. PubMed ID: 35156331
[TBL] [Abstract][Full Text] [Related]
18. Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.
Jin X; Luong TL; Reese N; Gaona H; Collazo-Velez V; Vuong C; Potter B; Sousa JC; Olmeda R; Li Q; Xie L; Zhang J; Zhang P; Reichard G; Melendez V; Marcsisin SR; Pybus BS
J Pharmacol Toxicol Methods; 2014; 70(2):188-94. PubMed ID: 25150934
[TBL] [Abstract][Full Text] [Related]
19. MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.
Reznicek J; Ceckova M; Ptackova Z; Martinec O; Tupova L; Cerveny L; Staud F
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696229
[TBL] [Abstract][Full Text] [Related]
20. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
Nies AT; Herrmann E; Brom M; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
